No Data
No Data
Insiders At Janux Therapeutics Sold US$1.3m In Stock, Alluding To Potential Weakness
Express News | HC Wainwright & Co. Reiterates Buy on Janux Therapeutics, Maintains $63 Price Target
H.C. Wainwright Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $63
Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Lyell Immunopharma (LYEL) and Janux Therapeutics Inc (JANX)
Southwest Airlines, Rocket Lab USA, and More Stocks See Action From Activist Investors -- Barrons.com
BTIG Initiates Janux Therapeutics(JANX.US) With Buy Rating, Announces Target Price $62